Thrivent Financial For Lutherans Axsome Therapeutics, Inc. Transaction History

Thrivent Financial For Lutherans

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $793,995 - $1.04 Million	-11,974 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$68.34 - $85.84 $6,834 - $8,584	-100 Reduced 0.83%	11,974 $853,000
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $497,448 - $1.22 Million	12,074 New	12,074 $710,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.